Home LiteratureArticle Details
PMID: 20463584 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients.

Journal of acquired immune deficiency syndromes (1999) ·Vol. 54 ·No. 5 ·2010-08-00 ·Pages 447-54

Sachdeva M, Fischl MA, Pahwa R, Sachdeva N, Pahwa S

Abstract

Chronic HIV-1 infection is associated with excessive immune activation and immune exhaustion. We investigated the relationship of these 2 phenotypes and frequency of regulatory T cells (Tregs) in controlled and uncontrolled chronic HIV-1 infection. Immune exhaustion marker PD-1, its ligand PD-L1, CD4CD25 FoxP3 Tregs, HLA-DR, and CD38 coexpression as activation markers were investigated in peripheral blood lymphocytes of 44 HIV-1-infected patients and 11 HIV-1-uninfected controls by multicolor flow cytometry. Activated and PD-1 expressing T cells were increased, and Tregs were decreased in HIV-1-infected patients as compared with controls, and alterations were greatest in viremic patients. The proportion of activated CD8 T cells exceeded activated CD4 T cells. Tregs had an inverse correlation with activated T cells and PD-1 expressing T cells. PD-L1 was highly expressed on monocytes and to a lesser extent on T lymphocytes of patients. These abnormalities partially reversed with virologic control after potent antiretroviral therapy. Immune exhaustion is a component of aberrant immune activation in chronic HIV-1 infection and is associated with loss of Tregs and ongoing virus replication. These defects are corrected partially with effective virologic control by potent antiretroviral therapy.

MeSH Terms
Adult Antigens, CD/analysis Chronic Disease Female Flow Cytometry HIV Infections/immunology HIV-1/immunology Humans Lymphocyte Activation Male T-Lymphocyte Subsets/chemistry,immunology T-Lymphocytes, Regulatory/immunology
Chemicals
Antigens, CD
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sachdeva Meenakshi
Department of Microbiology and Immunology, Developmental Center for AIDS Research, University of Miami-Miller School of Medicine, Miami, FL 33136, USA.
Fischl Margaret A
Pahwa Rajendra
Sachdeva Naresh
Pahwa Savita
References (35)
35 references, click to expand
  1. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.
    Blood. 2004 Nov 15;104(10):3249-56 PMID: 15271794
  2. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
    J Infect Dis. 2005 Mar 1;191(5):694-701 PMID: 15688282
  3. CD8 lymphocyte counts and serum immunoglobulin A levels early in HIV infection as predictors of CD4 lymphocyte depletion during 8 years of follow-up.
    AIDS. 1993 Jul;7(7):975-80 PMID: 8102854
  4. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value.
    Clin Exp Immunol. 1992 Dec;90(3):376-82 PMID: 1458674
  5. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    AIDS. 2007 Jul 31;21(12):1525-34 PMID: 17630546
  6. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.
    Blood. 2006 Dec 1;108(12):3808-17 PMID: 16902147
  7. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
    Cell Immunol. 2005 Jul-Aug;236(1-2):146-53 PMID: 16165113
  8. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    J Immunol. 2007 Aug 1;179(3):1979-87 PMID: 17641065
  9. T-cell costimulatory pathways in allograft rejection and tolerance.
    Immunol Rev. 2003 Dec;196:85-108 PMID: 14617200
  10. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Chin Med J (Engl). 2006 Dec 5;119(23):1966-71 PMID: 17199940
  11. Interaction of human PD-L1 and B7-1.
    Mol Immunol. 2008 Aug;45(13):3567-72 PMID: 18585785
  12. B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.
    Blood. 2003 Apr 1;101(7):2514-20 PMID: 12468426
  13. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy.
    AIDS. 2008 Oct 1;22(15):2035-8 PMID: 18784466
  14. Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
    Nat Med. 2006 Dec;12(12):1365-71 PMID: 17115046
  15. CD28/B7 costimulation: a review.
    Crit Rev Immunol. 1998;18(5):389-418 PMID: 9784967
  16. Restoring function in exhausted CD8 T cells during chronic viral infection.
    Nature. 2006 Feb 9;439(7077):682-7 PMID: 16382236
  17. Depletion of regulatory T cells in HIV infection is associated with immune activation.
    J Immunol. 2005 Apr 1;174(7):4407-14 PMID: 15778406
  18. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
    J Immunol. 2002 May 15;168(10):4897-906 PMID: 11994439
  19. Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection.
    Clin Exp Immunol. 2007 Mar;147(3):533-9 PMID: 17302904
  20. The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.
    J Immunol. 2005 Mar 15;174(6):3143-7 PMID: 15749840
  21. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses.
    Eur J Immunol. 2003 Oct;33(10):2706-16 PMID: 14515254
  22. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.
    J Infect Dis. 2009 May 1;199(9):1318-22 PMID: 19301980
  23. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.
    Int Immunol. 1996 May;8(5):765-72 PMID: 8671665
  24. Expression of programmed death 1 ligands by murine T cells and APC.
    J Immunol. 2002 Nov 15;169(10):5538-45 PMID: 12421930
  25. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.
    PLoS Biol. 2004 Jul;2(7):E198 PMID: 15252446
  26. The B7-CD28 superfamily.
    Nat Rev Immunol. 2002 Feb;2(2):116-26 PMID: 11910893
  27. PD-1 expression on human CD8 T cells depends on both state of differentiation and activation status.
    AIDS. 2007 Oct 1;21(15):2005-13 PMID: 17885290
  28. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Nature. 2006 Sep 21;443(7109):350-4 PMID: 16921384
  29. Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infection.
    J Immunol. 2009 Jul 15;183(2):1120-32 PMID: 19564339
  30. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction.
    Nat Med. 2006 Oct;12(10):1198-202 PMID: 16917489
  31. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Immunity. 2007 Jul;27(1):111-22 PMID: 17629517
  32. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands.
    AIDS. 2008 Mar 12;22(5):655-8 PMID: 18317010
  33. Immune activation and inflammation in HIV-1 infection: causes and consequences.
    J Pathol. 2008 Jan;214(2):231-41 PMID: 18161758
  34. Costimulatory regulation of T cell function.
    Curr Opin Cell Biol. 1999 Apr;11(2):203-10 PMID: 10209159
  35. T regulatory cells and HIV infection.
    AIDS Rev. 2007 Jan-Mar;9(1):54-60 PMID: 17474313
Article Info
Journal
Journal of acquired immune deficiency syndromes (1999)
Abbr.
J Acquir Immune Defic Syndr
ISSN
1944-7884
Published
2010-08-00
Pages
447-54
Language
English
Region
United States
NLM ID
100892005
PMCID
PMC3095513
Subset
IM
Grants
NIAID NIH HHS · U01 AI068632 · United States
NIAID NIH HHS · R01 AI077501 · United States
NIAID NIH HHS · P30 AI073961 · United States
NIAID NIH HHS · AI068632 · United States
NIAID NIH HHS · R01 AI077501-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]